Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40 | 130 | 170 | 360 | 320 |
| Receivables | 1,130 | 2,000 | 4,470 | 3,220 | 1,880 |
| Other current assets | 170 | 130 | 130 | 60 | 110 |
| TOTAL | $1,340 | $2,260 | $4,770 | $3,640 | $2,310 |
| Non-Current Assets | |||||
| PPE Net | 590 | 750 | 4,080 | 830 | 393 |
| Investments And Advances | 0 | 0 | 0 | 0 | 10 |
| Other Non-Current Assets | 60 | 70 | 140 | 4,580 | 570 |
| TOTAL | $650 | $820 | $4,220 | $5,410 | $973 |
| Total Assets | $2,020 | $3,110 | $9,000 | $9,010 | $3,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 700 | 120 |
| Accounts payable and accrued liabilities | 1,510 | 1,490 | 2,320 | 1,120 | 410 |
| Accrued Expenses | 420 | 1,000 | 1,780 | 1,170 | 320 |
| TOTAL | $2,530 | $3,000 | $5,910 | $3,020 | $870 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | N/A | 90 |
| TOTAL | $N/A | $N/A | $N/A | $10 | $130 |
| Total Liabilities | $2,530 | $3,000 | $5,910 | $3,030 | $1,030 |
| Shareholders' Equity | |||||
| Common Shares | 110 | 100 | 80 | 70 | 7 |
| Retained earnings | -13,690 | -12,910 | -8,780 | 230 | 1,790 |
| Other shareholders' equity | 160 | 150 | 140 | 160 | 153 |
| TOTAL | $-510 | $100 | $3,080 | $5,970 | $2,080 |
| Total Liabilities And Equity | $2,020 | $3,100 | $8,990 | $9,000 | $3,110 |